COURSE trial reveals promising results for TEZSPIRE in COPD patients with high eosinophil counts

In a significant development in chronic obstructive pulmonary disease (COPD) management, the Phase IIa COURSE trial, a proof-of-concept study led by AstraZeneca in partnership with ... Read More